RZH
VRTX icon

Relyea Zuckerberg Hanson’s Vertex Pharmaceuticals VRTX Stock Holding History

Relyea Zuckerberg Hanson’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$575K Buy
1,157
+330
+40% +$146K 0.05% 165
2026
Q1 		$369K Buy
827
+251
+44% +$117K 0.04% 195
2025
Q4 		$261K Buy
576
+22
+4% +$9.48K 0.03% 225
2025
Q3 		$217K Sell
554
-83
-13% -$34.7K 0.02% 253
2025
Q2 		$284K Sell
637
-125
-16% -$57.6K 0.03% 218
2025
Q1 		$369K Buy
762
+214
+39% +$99.7K 0.05% 183
2024
Q4 		$221K Sell
548
-20
-4% -$9.27K 0.03% 241
2024
Q3 		$264K Buy
568
+14
+3% +$6.72K 0.04% 211
2024
Q2 		$260K Buy
554
+37
+7% +$16.1K 0.04% 203
2024
Q1 		$216K Buy
517
+13
+3% +$5.5K 0.04% 217
2023
Q4 		$205K Buy
+504
New +$186K 0.04% 212

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Relyea Zuckerberg Hanson's VRTX Position: Q2 2026 in Review

Relyea Zuckerberg Hanson increased its Vertex Pharmaceuticals (VRTX) stake by 40% in Q2 2026, buying an estimated $146K and bringing the position to 1,157 shares worth $575K. The position accounts for 0.05% of the portfolio, ranked #165.

Relyea Zuckerberg Hanson first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Relyea Zuckerberg Hanson held 1,157 shares of Vertex Pharmaceuticals worth $575K as of Q2 2026.
  • Relyea Zuckerberg Hanson bought 330 Vertex Pharmaceuticals shares in Q2 2026, an estimated $146K.
  • Vertex Pharmaceuticals made up 0.05% of Relyea Zuckerberg Hanson's portfolio in Q2 2026, its #165 holding.
  • Relyea Zuckerberg Hanson first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Relyea Zuckerberg Hanson's 13F filing for Q2 2026, filed 16 Jul 2026.